Richard H. Scheller, See Remarks at BridgeBio Pharma, Inc. (BBIO), sold 62,886 shares at $60.73 ($3.8M) on 2020-12-15, disclosed to the SEC on 2020-12-17.
Open-market sale of $3.8M BBIO by See Remarks. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $59.81 | 12,091 | $723K | 19.0% |
| 2 | $59.81 | 12,091 | $723K | 19.0% |
| 3 | $60.73 | 19,352 | $1.2M | 31.0% |
| 4 | $60.73 | 19,352 | $1.2M | 31.0% |
| Total | $60.38 avg | 62,886 | $3.8M | 100% |
| Filing → |
| DICE | SELL | 2023-05-09 | $6.5M | — | Filing → |
| ME | SELL | 2022-11-14 | $119K | — | Filing → |
| ALEC | SELL | 2021-08-09 | $3.7M | — | Filing → |